Weather Alerts

Ames Pharmaceutical Company to Work on Ebola Vaccine

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

AMES, Iowa – A pharmaceutical company based in Ames is working on a vaccine for the deadly Ebola virus that has killed almost 900 people in Africa.

"We believe that we have a product that is very helpful in this situation. We believe it is as likely to be as effective in humans as in the non-human primates we've studied," said Jay Ramsey, Clinical & Regulatory Compliance Officer of NewLink Genetics.

NewLink Genetics has signed a contract with the federal government. The company will work on studies to bring the vaccine closer to human trials. The hope is that it will be ready for testing in a government hospital in a matter of months.

"We believe that the vaccine we have - which has been hugely successful in all animal models tested ... is ready to move forward into clinical testing," said Ramsey.

Officials said the vaccine has been 100% effective in preventing the infection when given to non-human primates.

The company just signed a preliminary contract with the government on Monday. It allows for $1 million in funding, that amount could be increased at a later time.

1 Comment

  • Non-Human Primates?

    Testing on non-human primates. Need more? Got a list as long as your arm, of mangers at work, past and present.

Comments are closed.